These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33792262)

  • 1. Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations.
    Berry AC; Gonnering RS; Rodriguez I; Zhang Q; Berry BB
    Rev Cardiovasc Med; 2021 Mar; 22(1):191-198. PubMed ID: 33792262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
    Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
    Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
    Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
    De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
    Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
    Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
    J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity.
    Desmarais J; Rosenbaum JT; Costenbader KH; Ginzler EM; Fett N; Goodman S; O'Dell J; Pineau CA; Schmajuk G; Werth VP; Link MS; Kovacs R
    Arthritis Rheumatol; 2021 Dec; 73(12):2151-2160. PubMed ID: 34697918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
    BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
    Pereira BB
    J Toxicol Environ Health B Crit Rev; 2020 May; 23(4):177-181. PubMed ID: 32281481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine treatment in COVID-19: A descriptive observational analysis of 30 cases from a single center in Wuhan, China.
    Xue H; Liu Y; Luo P; Liu X; Qiu L; Liu D; Li J
    J Med Virol; 2020 Nov; 92(11):2523-2527. PubMed ID: 32779755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review.
    Nadeem U; Raafey M; Kim G; Treger J; Pytel P; N Husain A; Schulte JJ
    Am J Clin Pathol; 2021 May; 155(6):793-801. PubMed ID: 33316045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
    Nicolò M; Ferro Desideri L; Bassetti M; Traverso CE
    Int Ophthalmol; 2021 Feb; 41(2):719-725. PubMed ID: 32946004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
    Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
    Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
    Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
    Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
    Derwand R; Scholz M
    Med Hypotheses; 2020 Sep; 142():109815. PubMed ID: 32408070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021.
    Schultz É; Atlani-Duault L; Peretti-Watel P; Ward JK
    Therapie; 2022; 77(5):591-602. PubMed ID: 35101281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.